Watch Your Health has announced the completion of a $5 million funding round led by Cornerstone Ventures from India and Conquest Global from Singapore . This capital raise will help the company scale operations and expand the user base both domestically and internationally by growing
The First Indo-Uzbek Pharma Business Forum was successfully held in Hyderabad, Telangana, focusing on trade and investment opportunities in the pharmaceutical sector between India and Uzbekistan. This landmark event was jointly organized by the Embassy of Uzbekistan in New Delhi, the Pharmaceutical Industry Development Agency
The UNICEF order for ceftriaxone supply is an endorsement of Venus Remedies’ exceptional quality standards and its position as a trusted partner in global healthcare supply chains The company also secures a mandate from the world's oldest international public health agency for supplying essential
Spearheading the shift towards Pharma 4.0 by leveraging the power of digital Building future-ready pharmaceutical production and biotech facilities to accelerate sustainability, resilience, and, agility Harnessing digital technologies for reducing ~70% CO2 emissions An IoT-enabled solution focused on water conservation, process electrification, sustainability by
Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced that Srinivas Sadu, the incumbent Managing Director (MD) and CEO, has been appointed as Executive Chairman and CEO of the company, effective June 10, 2024.Srinivas Sadu, a seasoned professional with
FY2024 Performance HighlightsHighest ever full-year Revenue of ₹40,555 million in FY24, up 14.4% YoY Highest ever full-year EBITDA of ₹7,477 million in FY24, up 77.6% YoY US business achieved top end of $250 million revenue outlook for FY24, grew by 11.8% YoY Net
In a recent announcement, 8chili, a pioneering deep tech company based in San Ramon, California and Bangalore, India, has announced a significant investment from strategic investor and mentor Karna D Shinde. This investment marks a milestone in 8chili's journey as it continues to lead the
The appointment is effective as of May 16, 2024. In her new role, Annapurna will lead the Company in India, ensuring patient access to its highly innovative medicines and vaccines, and advancing valuable collaborations to contribute to the growing domestic healthcare and pharmaceutical market.(TSE:4502/NYSE:TAK) Takeda Biopharmaceuticals
Sevelamer Carbonate Tablets approval consolidates the Company's position in the Sevelamer segment by complementing the existing approval of Sevelamer for Oral SuspensionStrides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval
By Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), New Delhi.The potential of the Indian medical devices industry is immense. With the implementation of enabling measures such as streamlining regulations, achieving self-reliance in domestic production and global competitiveness is very much within our
